Order Article Reprints

Liu N, Zhang H, Zhang C, Li Z, Huang L, Sun J, Qi J, Deng X, Huang N, Mu Y, et al. DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. Cancers. 2023; 15(21):5228. https://doi.org/10.3390/cancers15215228

Liu, Nanbin, Hailong Zhang, Chunli Zhang, Zeyu Li, Limin Huang, Jin Sun, Junan Qi, Xi Deng, Na Huang, Yanhua Mu, and et al. 2023. "DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC" Cancers 15, no. 21: 5228. https://doi.org/10.3390/cancers15215228

Liu, N., Zhang, H., Zhang, C., Li, Z., Huang, L., Sun, J., Qi, J., Deng, X., Huang, N., Mu, Y., Li, Z., & Tian, H. (2023). DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. Cancers, 15(21), 5228. https://doi.org/10.3390/cancers15215228